There are no established standards for treatment of neurosarcoidosis. Currently, the first-line standard of care is glucocorticosteroids, “despite the lack of conclusive data,” Dr. Sweiss advised. “DMARDs and TNF inhibitors are safe and effective, but remain investigational.”
You Might Also Like
Explore This IssueMarch 2015
Also By This Author
Kathy L. Holliman, MEd, is a medical writer based in Beverly, Mass.